High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial...
Nusano Announces Isotope Availability
read more
News
Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)
VALENCIA, Calif. – Dec. 11, 2024 – Nusano, a physics company transforming the production of radioisotopes, today...
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement
VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of...
Nusano Names Medical Radioisotopes Advisory Board
Nusano names five member Medical Radioisotope Advisory Board
Nusano to Present at William Blair Virtual Radiopharmaceuticals Event
VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today...
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
Image above: Starget Pharma, stargetpharma.comVALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates